| Registry | NCT00599677 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: triple, treatment |
| Enrollment | 720 (Actual) |
| Sponsor | Chengdu University of Traditional Chinese Medicine (Other) |
| Conditions | Functional Dyspepsia |
| Interventions | acupuncture, Itopride (Other, drug) |
| Dates | start 2007-11-01, primary completion 2009-09-01, completion 2009-09-01, first posted 2008-01-24, last updated 2011-11-09 |
| Locations | 1 site in China |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Functional Dyspepsia All trials of acupuncture All trials of Itopride
The purpose of the study is to testify the efficacy of treating functional dyspepsia with acupuncture, and provide evidence for the hypothesis that "Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."
The purpose of the study is to testify whether acupuncture is effective for functional dyspepsia, through treating functional dyspepsia patient for a month, using different acupoints according to literatures of treating migraine with acupuncture, and using Itopride as controlled group, and try to provide clinical evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."
| Arm | Type | Interventions | Description |
|---|---|---|---|
| group 1 | Experimental | Other: acupuncture | specific acupoints of Stomach meridians |
| group 2 | Experimental | Other: acupuncture | Non-specific acupoints of Stomach meridians |
| group 3 | Experimental | Other: acupuncture | alarm and transport points |
| group 4 | Experimental | Other: acupuncture | acupoints of the other meridian |
| group 5 | Sham comparator | Other: acupuncture | non-acupoints |
| group 6 | Active comparator | Drug: Itopride | Itopride |
Sex: All, ages: 18 Years to 65 Years
Inclusion Criteria: 1. Consistent with the diagnostic criteria of functional dyspepsia. 2. Age of a subject is older than 18 and is younger than 65.(including 18 and 65) 3. Did not take any gastroenteric dynamic drugs in the last 15 days, and did not take part in any clinical trial. 4. Informed consent is signed by a subject or his lineal relation. Exclusion Criteria: 1. Patients with any contraindications of Itopride. 2. Patients who are unconscious, psychotic. 3. Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding. 4. With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on. 5. Pregnant women or women in lactation.
| Facility | City | Country | Status |
|---|---|---|---|
| Chengdu University of TCM | Chengdu, Sichuan | China |